FindTrial
Sign In

cTACE

PROCEDURE8 trials

Sponsors

Air Force Military Medical University, China, Innovent Biologics (Suzhou) Co. Ltd., Beijing Tsinghua Chang Gung Hospital, Gao-jun Teng, InnoBM Pharmaceuticals Co., Ltd.

Conditions

DEB-TACEHepatocellular CarcinomaHepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-ResectableTACETIPSUnresectable Hepatocellular CarcinomacTACE

Phase 1

A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma
TerminatedNCT04635527
Innovent Biologics (Suzhou) Co. Ltd.Hepatocellular Carcinoma
Start: 2020-12-24End: 2023-03-07Updated: 2023-03-16

Phase 3

TACE With Dicycloplatin(TP21) in Unresectable HCC
NCT05472896
Gao-jun TengHepatocellular Carcinoma
Start: 2022-06-09End: 2024-06-30Target: 332Updated: 2022-07-25
A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma
Not yet recruitingNCT06779461
InnoBM Pharmaceuticals Co., Ltd.Hepatocellular Carcinoma Non-Resectable
Start: 2025-01-31End: 2027-12-31Target: 228Updated: 2025-01-16
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
RecruitingNCT06900543
Chengdu New Radiomedicine Technology Co. LTD.Unresectable Hepatocellular Carcinoma
Start: 2025-04-15End: 2027-12-31Target: 108Updated: 2025-05-20
DEB-TACE vs cTACE in HCC After TIPS
RecruitingNCT07322848
First Affiliated Hospital, Sun Yat-Sen UniversitycTACE, DEB-TACE, Hepatocellular Carcinoma (HCC) +2
Start: 2025-12-01End: 2029-12-31Target: 206Updated: 2026-01-07

Unknown Phase

Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC)
NCT03969576
Air Force Military Medical University, ChinaHepatocellular Carcinoma
Start: 2020-09-15End: 2022-06-15Target: 344Updated: 2020-02-05
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
NCT04738188
Beijing Tsinghua Chang Gung HospitalHepatocellular Carcinoma
Start: 2020-03-18End: 2025-12-31Target: 226Updated: 2021-02-04
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
RecruitingNCT06909708
Zhongda HospitalUnresectable Hepatocellular Carcinoma
Start: 2025-04-03End: 2027-01-30Target: 108Updated: 2025-04-09